Transfused macrophages ameliorate pancreatic and renal injury in murine diabetes mellitus

Nephron - Experimental Nephrology

Volumn 118, Issue 4, 2011, Pages

  Zheng, Dong ^a   Wang, Yiping ^a   Cao, Qi ^a   Lee, Vincent W S ^a   Zheng, Guoping ^a   Sun, Yan ^a   Tan, Thian K ^a   Wang, Ya ^a   Alexander, Stephen I ^b   Harris, David C H ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Cell transfer; Diabetic nephropathy; Macrophages

Indexed keywords

CYTOKINE; HEMOGLOBIN A1C; INTERLEUKIN 13; INTERLEUKIN 4;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL TRANSFER; CONTROLLED STUDY; CYTOKINE RELEASE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; KIDNEY INJURY; M2 MACROPHAGE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PANCREAS INJURY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANIMALS; BLOOD GLUCOSE; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; KIDNEY DISEASES; LEUKOCYTE TRANSFUSION; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; PANCREATIC DISEASES; SPLEEN;

EID: 79751527661     PISSN: 16602129     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000321034     Document Type: Article

References (39)

1. Furuta T, Saito T, Ootaka T, et al: The role of macrophages in diabetic glomerulosclerosis. Am J Kidney Dis 1993; 21: 480-485. (Pubitemid 23160508)
2. Nguyen D, Ping F, Mu W, et al: Macrophage accumulation in human progressive diabetic nephropathy. Nephrology (Carlton) 2006; 11: 226-231. (Pubitemid 43829442)
3. Chow FY, Nikolic-Paterson DJ, Ozols E, et al: Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney Int 2006; 69: 73-80. (Pubitemid 43117741)
4. Wang Y, Cao Q, Zheng G, et al: By homing to the kidney, activated macrophages potently exacerbate renal injury. Am J Pathol 2008; 172: 1491-1499. (Pubitemid 351793343)
5. Ruster C, Wolf G: The role of chemokines and chemokine receptors in diabetic nephropathy. Front Biosci 2008; 13: 944-955. (Pubitemid 351594739)
6. Kelly DJ, Wilkinson-Berka JL, Ricardo SD, et al: Progression of tubulointerstitial injury by osteopontin-induced macrophage recruitment in advanced diabetic nephropathy of transgenic (mRen-2)27 rats. Nephrol Dial Transplant 2002; 17: 985-991. (Pubitemid 34746199)
7. Mosser DM, Edwards JP: Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8: 958-969.
8. Kluth DC, Ainslie CV, Pearce WP, et al: Macrophages transfected with adenovirus to express IL-4 reduce inflammation in experimental glomerulonephritis. J Immunol 2001; 166: 4728-4736. (Pubitemid 32233761)
9. Wilson HM, Stewart KN, Brown PA, et al: Bone-marrow-derived macrophages genetically modified to produce IL-10 reduce injury in experimental glomerulonephritis. Mol Ther 2002; 6: 710-717. (Pubitemid 36054304)
10. Wilson HM, Chettibi S, Jobin C, et al: Inhibition of macrophage nuclear factor-kappaB leads to a dominant anti-inflammatory phenotype that attenuates glomerular inflammation in vivo. Am J Pathol 2005; 167: 27-37. (Pubitemid 40884767)
11. Polak J, Hench L: Gene therapy progress and prospects in tissue engineering. Gene Ther 2005; 12: 1725-1733. (Pubitemid 41760285)
12. Ikezumi Y, Atkins RC, Nikolic-Paterson DJ: Interferon-gamma augments acute macrophage-mediated renal injury via a glucocorticoid-sensitive mechanism. J Am Soc Nephrol 2003; 14: 888-898. (Pubitemid 36359271)
13. Wang Y, Wang YP, Zheng G, et al: Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney Int 2007; 72: 290-299. (Pubitemid 47172367)
14. Cao Q, Wang L, Du F, et al: Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells. Cell Res 2007; 17: 627-637. (Pubitemid 47116358)
15. Rangan GK, Tesch GH: Quantification of renal pathology by image analysis. Nephrology (Carlton) 2007; 12: 553-558.
16. Lacasa D, Taleb S, Keophiphath M, et al: Macrophage-secreted factors impair human adipogenesis: Involvement of proinflammatory state in preadipocytes. Endocrinology 2007; 148: 868-877. (Pubitemid 46143186)
17. Wang Y, Wang YP, Tay YC, et al: Progressive adriamycin nephropathy in mice: Sequence of histologic and immunohistochemical events. Kidney Int 2000; 58: 1797-1804.
18. Hasegawa G, Nakano K, Sawada M, et al: Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy. Kidney Int 1991; 40: 1007-1012.
19. Sassy-Prigent C, Heudes D, Mandet C, et al: Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes 2000; 49: 466-475. (Pubitemid 30131794)
20. Pawluczyk IZ, Harris KP: Macrophages promote prosclerotic responses in cultured rat mesangial cells: A mechanism for the initiation of glomerulosclerosis. J Am Soc Nephrol 1997; 8: 1525-1536. (Pubitemid 27496470)
21. Imani F, Horii Y, Suthanthiran M, et al: Advanced glycosylation end product-specific receptors on human and rat T-lymphocytes mediate synthesis of interferon gamma: Role in tissue remodeling. J Exp Med 1993; 178: 2165-2172. (Pubitemid 23344874)
22. Tay YC, Wang Y, Kairaitis L, et al: Can murine diabetic nephropathy be separated from superimposed acute renal failure? Kidney Int 2005; 68: 391-398. (Pubitemid 43181399)
23. Chung YH, Jun HS, Kang Y, et al: Role of macrophages and macrophage-derived cytokines in the pathogenesis of Kilham rat virus-induced autoimmune diabetes in diabetes-resistant BioBreeding rats. J Immunol 1997; 159: 466-471. (Pubitemid 127493733)
24. Rabinovitch A, Suarez-Pinzon WL, et al: Inducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice: Identification of iNOS-expressing cells and relationships to cytokines expressed in the islets. Endocrinology 1996; 137: 2093-2099. (Pubitemid 26133980)
25. Ogawa D, Shikata K, Matsuda M, et al: Protective effect of a novel and selective inhibitor of inducible nitric oxide synthase on experimental crescentic glomerulonephritis in WKY rats. Nephrol Dial Transplant 2002; 17: 2117-2121. (Pubitemid 35446666)
26. Liu J, Beller DI: Distinct pathways for NFkappa B regulation are associated with aberrant macrophage IL-12 production in lupusand diabetes-prone mouse strains. J Immunol 2003; 170: 4489-4496. (Pubitemid 36519954)
27. Taal MW, Zandi-Nejad K, Weening B, et al: Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney. Kidney Int 2000; 58: 1664-1676.
28. Wen Y, Gu J, Li SL, et al: Elevated glucose and diabetes promote interleukin-12 cytokine gene expression in mouse macrophages. Endocrinology 2006; 147: 2518-2525.
29. Thomson SC, Vallon V, Blantz RC: Kidney function in early diabetes: The tubular hypothesis of glomerular filtration. Am J Physiol Renal Physiol 2004; 286:F8-F15. (Pubitemid 38045037)
30. Rojas M, Bell TD, Sturgis LC, et al: Blood pressure early in diabetes depends on a balance between glomerular filtration rate and the renin-angiotensin system. Am J Hypertens 2006; 19: 1249-1255. (Pubitemid 44856823)
31. Hanenberg H, Kolb-Bachofen V, Kantwerk-Funke G, et al: Macrophage infiltration precedes and is a prerequisite for lymphocytic insulitis in pancreatic islets of pre-diabetic BB rats. Diabetologia 1989; 32: 126-134. (Pubitemid 19096385)
32. Jansen A, Homo-Delarche F, Hooijkaas H, et al: Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and beta-cell destruction in NOD mice. Diabetes 1994; 43: 667-675. (Pubitemid 24138780)
33. Rosmalen JG, Homo-Delarche F, Durant S, et al: Islet abnormalities associated with an early influx of dendritic cells and macrophages in NOD and NODscid mice. Lab Invest 2000; 80: 769-777. (Pubitemid 30340661)
34. Papaccio G, De Luca B, Pisanti FA: Macrophages and antioxidant status in the NOD mouse pancreas. J Cell Biochem 1998; 71: 479-490. (Pubitemid 28521003)
35. Kolb-Bachofen V, Epstein S, Kiesel U, et al: Low-dose streptozocin-induced diabetes in mice: Electron microscopy reveals single-cell insulitis before diabetes onset. Diabetes 1988; 37: 21-27. (Pubitemid 18036452)
36. Bleich D, Chen S, Zipser B, et al: Resistance to type 1 diabetes induction in 12-lipoxygenase knockout mice. J Clin Invest 1999; 103: 1431-1436. (Pubitemid 29535499)
37. Takamura T, Ando H, Nagai Y, et al: Pioglitazone prevents mice from multiple low-dose streptozotocin-induced insulitis and diabetes. Diabetes Res Clin Pract 1999; 44: 107-114. (Pubitemid 29447676)
38. Emre Y, Hurtaud C, Karaca M, et al: Role of uncoupling protein UCP2 in cell-mediated immunity: How macrophage-mediated insulitis is accelerated in a model of autoimmune diabetes. Proc Natl Acad Sci USA 2007; 104: 19085-19090.
39. Tang Q, Henriksen KJ, Bi M, et al: In vitroexpanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 2004; 199: 1455-1465.s (Pubitemid 38780401)